FDA Adverse Event Malfunction Summary report: N

IGG ANTIBODIES TO RUBELLA VIRUS

MDR report key: 4996684 · Received August 12, 2015

Report

Report Number
1823260-2015-03958
Event Type
Malfunction
Date Received
August 12, 2015
Date of Event
July 22, 2015
Report Date
October 6, 2015
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFX
PMA / PMN Number
K072617
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATIONS OF QUALITY CONTROL RELEASE DATA HAVE CONFIRMED THAT RECOVERY WITH KIT LOT 185927 IS SLIGHTLY HIGHER WHEN COMPARED TO KIT LOT 182963. HOWEVER, THE RECOVERY IS WITHIN SPECIFICATIONS FOR BOTH REAGENT LOTS.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(4). (B)(6).

Additional Manufacturer Narrative · 1

THE INVESTIGATION DETERMINED THAT SAMPLES WITH A CONCENTRATION CLOSE TO THE CUT-OFF MAY GIVE DIFFERENT QUALITATIVE RESULTS, NON-REACTIVE VERSUS REACTIVE.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THEY SAW AN IMPLAUSIBLE SHIFT UP IN PATIENT RESULTS WHEN SWITCHING FROM IGG ANTIBODIES TO RUBELLA VIRUS (RUBELLA IGG) REAGENT LOT NUMBER 182963 TO LOT NUMBER 185927. MONITORING THE TWO AFFECTED PATIENTS OVER TIME REVEALED THE UP-SHIFT OF RUBELLA IGG VALUES. THE RESULTS FOR TWO PATIENT SAMPLES WERE PROVIDED AND RESULTS FROM REAGENT LOT NUMBER 185927 WERE CONSIDERED TO BE ERRONEOUS (FALSELY POSITIVE).THE RESULTS FOR EACH PATIENT WERE REPORTED OUTSIDE OF THE LABORATORY AND EACH PATIENT'S PHYSICIAN QUESTIONED THE UP-SHIFT IN RESULTS. THE FIRST PATIENT SAMPLE INITIALLY RESULTED AS 9.15 IU/ML WITH REAGENT LOT NUMBER 182963. THE SAMPLE WAS REPEATED WITH REAGENT LOT NUMBER 185927 AND RESULTED AS 15.99 IU/ML. THE SECOND PATIENT SAMPLE INITIALLY RESULTED AS 9.49 IU/ML WITH REAGENT LOT NUMBER 182963. THE SAMPLE WAS REPEATED WITH REAGENT LOT NUMBER 185927 AND RESULTED AS 11.68 IU/ML. THE SAMPLE WAS ALSO REPEATED A SECOND TIME WITH REAGENT LOT NUMBER 185927 AND RESULTED AS 11.87 IU/ML. THE PATIENTS WERE NOT ADVERSELY AFFECTED. THE SAMPLES WERE TESTED ON AND E602 MODULE ANALYZER SERIAL NUMBER (B)(4). CONTROL RECOVERY FOR EACH LOT NUMBER WAS FOUND TO BE WITHIN EXPECTED RANGES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
531525 IGG ANTIBODIES TO RUBELLA VIRUS ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA LFX ROCHE DIAGNOSTICS NA 185927

Patients

Seq Age Sex Outcome Treatment
1